Roger Legtenberg, PhD
Roger Legtenberg is Chief Executive Officer (CEO) of SERPINx. He has a strong history of 18 years in Life Sciences. Roger has a background in Biomedical Chemistry and obtained his PhD in Medicine (Diabetes/Cardiovascular) in 2001 (Radboud University Nijmegen).
Until 2009 he held Project Manager, Clinical Research Manager and Director Business Development positions. From 2010 until end of 2018, he was co-owner and CEO of PSR Orphan Experts, a specialized clinical CRO focused on rare diseases (in a wide range of therapeutic indications). He succesfully led the organizational transformation finding it’s true purpose and utilizing Lean & How (Golden Circle) principles. Under his leadership significant growth in staff, finances and most importantly impact for the rare disease community was achieved. In 2017 PSR was acquired by Ergomed plc.
Roger is recipient of the 2018 CEO Today Europe & 2018 International Life Sciences GHP Drug Development CEO awards. He also previously served as board member of ACRON and BioFarmind (now HollandBio).
Roger founded Up Strong early 2019 to passionately contribute to companies and all other stakeholders in the industry with their (upcoming) challenges on business development, strategy and (interim-) management with a clear focus on what really matters: the patient’s need.